Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nicotine therapy for ulcerative colitis

L D Kennedy1

  • 1Department of Pharmacy, North Carolina Baptist Hospitals, Inc., Medical Center Blvd, Winston-Salem, USA.

The Annals of Pharmacotherapy
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention and treatment of veno-occlusive disease.

The Annals of pharmacotherapy·2001
Same author

Earnings histories of SSI beneficiaries working in December 1997.

Social security bulletin·2001
Same author

Practice guidelines for lipid-based amphotericin B in stem cell transplant recipients.

The Annals of pharmacotherapy·2001
Same author

SSI at its 25th year.

Social security bulletin·1999
Same author

Noncitizens and the Supplemental Security Income program.

Social security bulletin·1999
Same author

Hydroxyurea in the treatment of sickle-cell anemia.

The Annals of pharmacotherapy·1997
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
Same journal

Modified vs Full Lead-in Dose Apixaban and Rivaroxaban for Treatment of Acute Venous Thromboembolism.

The Annals of pharmacotherapy·2026
Same journal

A Comparison of Phenobarbital Dosing Strategies for the Treatment of Alcohol Withdrawal Syndrome.

The Annals of pharmacotherapy·2026
See all related articles

Nicotine therapy shows limited benefit for ulcerative colitis (UC) treatment, with many patients experiencing side effects or placebo relief. Further research is needed before nicotine can be recommended for UC management.

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Smoking is linked to a lower incidence of ulcerative colitis (UC).
  • The therapeutic role of nicotine for UC treatment remains unclear.
  • Existing studies on nicotine for UC have used varied dosages and designs.

Purpose of the Study:

  • To evaluate the established role of nicotine in ulcerative colitis (UC) treatment.
  • To compare nicotine therapy with other treatment modalities for UC.
  • To assess the safety and efficacy of nicotine for UC.

Main Methods:

  • Review of studies evaluating nicotine gum and transdermal patches for stable UC.
  • Analysis of nicotine dosages ranging from 5 to 30 mg/d.
  • Consideration of adverse effects and placebo response rates.

Related Experiment Videos

Main Results:

  • Nicotine therapy has not been directly compared to other UC treatments.
  • No clear dose-related therapeutic effects of nicotine were observed.
  • Adverse effects like nausea, light-headedness, and headache were common.
  • Significant patient relief was reported with placebo treatments.

Conclusions:

  • Nicotine therapy is generally not recommended for ulcerative colitis (UC) treatment at this time.
  • The cyclic nature of UC and nicotine's addictive potential necessitate further investigation.
  • Future research should employ randomized, double-blind designs with extended follow-up periods to clarify nicotine's benefits for UC.